TABLE 1.
CircRNA (circBase ID or alternative titles based on the gene name or its position on a chromosome) | Samples | GEO database | Methods | Identi fied circR NAs | Differen tially express ed | Upregula ted circRNAs | Downreg ulated circRNAs | Ref. | |
---|---|---|---|---|---|---|---|---|---|
CircRNAs that are upregulated (↑) in thyroid cancer samples compared to control | |||||||||
1) hsa_circ_0061406 (circTIAM1) | Tissues | GSE168449 | RNA-seq + qRT- PCR in 60 PTC and ANT | / | 50 | 25 | 25 | Zhang et al. (2022) | |
PTC | ANT | ||||||||
3 | 3 | ||||||||
2) hsa_circ_0002360 (circRUNX1) | Tissues | / | RNA-seq + qRT- PCR in 52 PTC and ANT | / | 100 | 100 | / | Chu et al. (2021) | |
PTC | ANT | ||||||||
3 | 3 | ||||||||
3) hsa_circ_0102272 | Tissues | / | RNA-seq + qRT- PCR for 58 TC patients | / | 54 | 35 | 19 | Liu et al. (2020b) | |
TC | ANT | ||||||||
5 | 5 | ||||||||
4) circRNA-UMAD1 | Serum | RNA-seq | / | 392 | 208 | 184 | Yu et al. (2020) | ||
Invasive TC | TC | ||||||||
2 | 2 | ||||||||
5) hsa_circ_104566 (hsa_circ_0004458) | Tissues | GSE93522 | Microarray + qRT-PCR for PTC and ANT samples | / | 98 | 88 | 10 | Peng et al. (2017) | |
6) hsa_circ_104565 (hsa_circ_0002111) | PTC | ANT | |||||||
7) hsa_circ_104595 (hsa_circ_0008016) | 6 | 6 | |||||||
8) hsa_circ_103110 (hsa_circ_0004771) | |||||||||
9) hsa_circ_105038 (hsa_circ_0091894) | |||||||||
10) hsa_circ_400064 (hsa_circ_0092315) | |||||||||
11) hsa_circ_104268 (hsa_circ_0078738) | |||||||||
12) hsa_circ_103307 (hsa_circ_0064557) | PTC | BTL | |||||||
13) hsa_circ_001379 (hsa_circ_0000516) | 6 | 6 | |||||||
14) hsa_circ_101356 (hsa_circ_0004846) | |||||||||
15) hsa_circ_102002 (hsa_circ_0003505) | |||||||||
16) hsa_circ_104433 (hsa_circ_0081342) | |||||||||
17) hsa_circ_0000277 | Tissues | GSE173299 | Microarrays + qRT-PCR for 57 PTC and ANT patients | / | 158 | 74 | 84 | Guo et al. (2021) | |
18) hsa_circ_0074530 | PTC | ANT | |||||||
19) hsa_circ_0057691 | 3 | 3 | |||||||
20) hsa_circRNA000121 | Tissues | / | Microarrays + qRT-PCR | / | 690 | 400 | 290 | Yang et al. (2020c) | |
21) hsa_circRNA051239 | Invasive PTMC | PTMC | |||||||
22) hsa_circRNA001059 | 13 | 13 | |||||||
23) hsa_circRNA102116 | |||||||||
24) hsa_circRNA000466 | |||||||||
25) circ_0004053 | Tissues | GSE93522 | Microarrays | / | 137 | 115 | 22 | Qiu et al. (2021) | |
26) circ_0028198 | PTC | ANT | |||||||
6 | 6 | ||||||||
27) hsa_circ_007293 | Exosomes (serum) | / | Microarrays + qRT-PCR | / | 22 | 3 | 19 | Yang et al. (2019) | |
28) hsa_circ_031752 | PTC | BTL | |||||||
3 | 3 | ||||||||
29) chr20:20425608‑20472956‑ | Tissues | / | RNA-seq + qRT- PCR in 45 PTC and ANT patients | / | 53 | 45 | 8 | Guo et al. (2020a) | |
30) chr5:161330882‑161336769‑ | PTC | ANT | |||||||
31) chr7:22308338‑22318037 | 5 | 5 | |||||||
32) hsa_circ_0082002 | |||||||||
33) hsa_circ_0002111 | |||||||||
34) hsa_circ_0008796 | |||||||||
35) chr7: 116695750–116700284+ | Tissues | GSE171011 | RNA-seq + qRT- PCR | 16569 | 720 | 301 | 419 | Lv et al. (2021) | |
36) chr7:116699071–116700284+ | PTC | ANT | |||||||
37) chr5: 161330883–161336769− | 4 | 4 | |||||||
38) chr4: 25665378–25667298+ | |||||||||
39) chr1: 12578718–12579412− | |||||||||
40) hsa_circ_0124055 | Tissues | / | RNA-seq + qRT-PCR for 66 TC patients | / | 231 | 133 | 98 | Sun et al. (2020b) | |
41) hsa_circ_0101622 | TC | ANT | |||||||
5 | 5 | ||||||||
42) hsa_circ_0004458 | Tissues | GSE93522 | Microarrays and RNA-Seq | / | 14 | 14 | / | Liu et al. (2020d) | |
PTC | ANT | ||||||||
6 | 6 | ||||||||
43) chr5:160757890-160763776− | Tissues | / | RNA-seq + qRT- PCR for 87 PTC patients | 9103 | 87 | 41 | 46 | Lan et al. (2018b) | |
44) chr12:40696591-40697936+ | PTC | ANT | |||||||
45) chr7:22330794-22357656− | 3 | 3 | |||||||
46) chr21:16386665-16415895− | |||||||||
47) hsa_circRNA_007148 | Tissues | / | Microarrays + qRT-PCR for 40 PTC patients | / | 383 | 206 | 177 | Ren et al. (2018) | |
PTC | ANT | ||||||||
3 | 3 | ||||||||
48) hsa_circ_406841 | FRO cell line | / | Microarrays + qRT-PCR | / | 50 | 25 | 25 | Hou et al. (2018) | |
49) hsa_circ_00905 | AGPS sh and KO groups compared with the control group | ||||||||
50) hsa_circ_019252 | |||||||||
51) hsa_circ_089761 | |||||||||
52) hsa_circ_006050 | |||||||||
53) hsa_circ_074298 | |||||||||
54) hsa_circ_066556 | |||||||||
55) hsa_circ_101321 | |||||||||
56) hsa_circ_023016 | |||||||||
57) hsa_circ_019744 | |||||||||
CircRNAs that are downregulated (↓) in thyroid cancer samples compared to control | |||||||||
1) hsa_circ_IPCEF1 | Tissues | GSE173299 | Microarrays + qRT-PCR for 57 PTC and ANT | / | 158 | 74 | 84 | Guo et al. (2021) | |
PTC | ANT | ||||||||
3 | 3 | ||||||||
2) hsa_circ_0077514 (circHACE1) | Tissues | GSE93522 | Microarrays + qRT-PCR | / | 20 | 10 | 10 | Li et al. (2021b) | |
PTC | ANT | ||||||||
6 | 6 | ||||||||
3) hsa_circ_0007694 | Tissues | / | qRT-PCR + RNA-seq in 3 PTC and ANT | / | 129 | 87 | 42 | Long et al. (2020) | |
PTC | ANT | ||||||||
12 | 12 | ||||||||
4) hsa_circ_100777 (hsa_circ_0021553) | Tissues | GSE93522 | Microarray + qRT-PCR for PTC and ANT samples | / | Peng et al. (2017) | ||||
5) hsa_circ_100395 (hsa_circ_0015278) | PTC | ANT | 98 | 88 | 10 | ||||
6) hsa_circ_104348 (hsa_circ_0079891) | 6 | 6 | |||||||
7) hsa_circ_103454 (hsa_circ_0067103) | PTC | BTL | 355 | 129 | 226 | ||||
6 | 6 | ||||||||
8) hsa_circ_0020396 | Tissues | GSE173299 | Microarrays + qRT-PCR for 57 PTC and ANT patients | / | 158 | 74 | 84 | Guo et al. (2021) | |
9) hsa_circ_0095448 | PTC | ANT | |||||||
10) hsa_circ_IPCEF1 | 3 | 3 | |||||||
11) hsa_circ_0021549 | |||||||||
12) hsa_circRNA404686 | Tissues | / | Microarrays + qRT-PCR | / | 690 | 400 | 290 | Yang et al. (2020d) | |
13) hsa_circRNA001729 | Invasive PTMC | PTMC | |||||||
14) hsa_circRNA404686 | 13 | 13 | |||||||
15) hsa_circRNA004183 | |||||||||
16) hsa_circRNA102051 | |||||||||
17) hsa_circRNA405571 | |||||||||
18) hsa_circ_020135 | Exosomes (serum) | / | Microarrays + qRT- PCR | / | 22 | 3 | 19 | Yang et al. (2019) | |
PTC | BTL | ||||||||
3 | 3 | ||||||||
19) hsa_circ_0072309 | Tissues | / | RNA-seq + qRT- PCR in 45 PTC and ANT | / | 53 | 45 | 8 | Guo et al. (2020a) | |
PTC | ANT | ||||||||
5 | 5 | ||||||||
20) chr5: 38481299–38530666 | Tissues | GSE171011 | RNA-seq + qRT- PCR | 16569 | 720 | 301 | 419 | Lv et al. (2021) | |
21) chr2: 159932176–159945082− | PTC | ANT | |||||||
22) chr10: 179994–249088+ | 4 | 4 | |||||||
23) chr3: 121378716–121381532+ | |||||||||
24) chr1: 237423092–237445522+ | |||||||||
25) hsa_circ_0067934 | Tissues | GSE93522 | Microarrays and RNA-Seq | / | 14 | 14 | / | Liu et al. (2020d) | |
26) hsa_circ_0000673 | PTC | ANT | |||||||
6 | 6 | ||||||||
27) chr22:36006931-36007153− | Tissues | / | RNA-seq + qRT- PCR for 87 PTC patients | 9103 | 87 | 41 | 46 | Lan et al. (2018b) | |
28) chr7:91924203-91957214+ | PTC | ANT | |||||||
29) chr2:179514891-179516047− | 3 | 3 | |||||||
30) chr9:16435553-16437522− | 3 | 3 | |||||||
31) hsa_circRNA_047771 | Tissues | / | Microarrays + qRT-PCR for 40 PTC patients | / | 383 | 206 | 177 | Ren et al. (2018) | |
PTC | ANT | ||||||||
3 | 3 | ||||||||
32) hsa_circ_404686 | FRO cell line | / | Microarrays + qRT-PCR | / | 50 | 25 | 25 | Hou et al. (2018) | |
33) hsa_circ_00367 | AGPS sh and KO groups compared with the control group | ||||||||
34) hsa_circ_001729 | |||||||||
35) hsa_circ_004183 | |||||||||
36) hsa_circ_100790 | |||||||||
37) hsa_circ_104270 | |||||||||
38) hsa_circ_102049 | |||||||||
39) hsa_circ_406494 | |||||||||
40) hsa_circ_100787 | |||||||||
41) hsa_circ_082319 |
Abbreviations: PTC:papillary thyroid cancer, ANT: adjacent non-tumor tissue, BTL:benign thyroid lesion, PTMC: papillary thyroid microcarcinoma, qRT-PCR: quantitative reverse transcriptase-polymerase chain reaction, RNA-Seq: RNA sequencing. AGPS: alkylglycerone phosphate synthase, sh: short hairpin, KO:knockout.